** Shares of blank-check company LWAC.O rise 28.3%
premarket and are set to touch a record high of $11.24 at the
open
** LWAC says the majority of its stockholders voted in favor
of a proposed buyout of cancer biotech eFFECTOR Therapeutics
urn:newsml:reuters.com:*:nGNX1mQ7vT
** Co says the deal, which was first proposed in May, will
provide total cash proceeds of about $65.9 mln, including ~$60
mln from PIPE funding urn:newsml:reuters.com:*:nGNX3T48zz
** LWAC said deal is expected to close on or around
Wednesday; combined co will begin trading stock and warrants on
Nasdaq under ticker symbols "EFTR" and "EFTRW" from around
Thursday
** Up to Tuesday's close, LWAC is down 12.4% from its IPO
price of $10 in February
(Reporting by Ruhi Soni in Bengaluru;)
((Ruhi.Soni@thomsonreuters.com;))